Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome

Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome

Abstract Background Polycystic ovary syndrome (PCOS) is a complex condition with high risk for dyslipidemia, dysglycemia, venous thromboembolism, cardiovascular disease and metabolic syndrome. Because the combined oral contraceptive (COC) use has also been associated with impaired fasting glucose, i...

Full description

Bibliographic Details
Main Author: Sebastião Freitas de Medeiros
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Reproductive Biology and Endocrinology
Subjects:
Polycystic ovary syndrome
Contraception
Oral contraceptive
Progestin
Venous thromboembolism
Dyslipidemia
Online Access:http://link.springer.com/article/10.1186/s12958-017-0313-y

Internet

http://link.springer.com/article/10.1186/s12958-017-0313-y

Similar Items